GLP-1 Agonists in Serious Mental Illness: Current Evidence

0:00-15:27

In this episode, we explore whether GLP-1 agonists like semaglutide can tackle the metabolic toll of antipsychotics in schizophrenia. Can a drug famous for celebrity weight loss actually protect our most vulnerable psychiatric patients from diabetes and obesity before the damage is done? Faculty: Oliver Freudenreich, M.D., F.A.C.L.P. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 84 GLP-1s in Schizophrenia: Should Semaglutide Be Added for Metabolic Management?

Publisher

Psychopharmacology and Psychiatry Updates

Link

psychopharmacology.libsyn.com/glp-1-agonists-in-serious-mental-illness-current-evidence

Published

August 29, 2026

Duration

15 min

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

Psychopharmacology Institute

PA

Psychopharmacology and Psychiatry Updates

@psychopharmacologyandpsychia

#agonists #seriousmentalillness #currentevidence #medicine

The Nile